# Cardiotoxicity of Cancer Therapy (CCT)

> **NCT01173341** · — · ENROLLING_BY_INVITATION · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 700 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Echocardiography
- **OTHER:** Blood Collection
- **OTHER:** Symptoms Questionnaire

## Key facts

- **NCT ID:** NCT01173341
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2010-07
- **Primary completion:** 2037-04
- **Final completion:** 2037-04
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173341, "Cardiotoxicity of Cancer Therapy (CCT)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01173341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*